Periplasmic Chaperones Used to Enhance Functional Secretion of Proteins in E. coli

Methods in Molecular Biology

Volumn 705, Issue , 2011, Pages 211-224

  Schlapschy, Martin ^a   Skerra, Arne ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chaperone; disulfide isomerase; DsbA; DsbC; FkpA; folding catalyst; peptidyl prolyl cis trans isomerase; SurA

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA;

CHAPERONE; DISULFIDE; DSBA PROTEIN, E COLI; DSBC PROTEIN, E COLI; EPIDERMAL GROWTH FACTOR; ESCHERICHIA COLI PROTEIN; PERIPLASMIC PROTEIN; PROTEIN DISULFIDE ISOMERASE; RECOMBINANT PROTEIN;

CYTOPLASM; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PLASMID; PROTEIN FOLDING; REVIEW; SECRETION;

DISULFIDES; EPIDERMAL GROWTH FACTOR; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MOLECULAR CHAPERONES; OXIDATION-REDUCTION; PERIPLASM; PERIPLASMIC PROTEINS; PLASMIDS; PROTEIN DISULFIDE-ISOMERASES; PROTEIN FOLDING; RECOMBINANT PROTEINS;

EID: 79952473873     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-967-3_12     Document Type: Chapter

References (51)

1. Georgiou, G., Segatori, L. (2005) Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 16, 538–545.
2. Mergulhao, F. J., Summers, D. K., Monteiro, G. A. (2005) Recombinant protein secretion in Escherichia coli. Biotechnol Adv 23, 177–202.
3. Skerra, A. (1993) Bacterial expression of immunoglobulin fragments. Curr Opin Immunol 5, 256–262.
4. Humphreys, D. P. (2003) Production of antibodies and antibody fragments in Escherichia coli and a comparison of their functions, uses and modification. Curr Opin Drug Discov Develop 6, 188–196.
5. Skerra, A., Plückthun, A. (1991) Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines. Protein Eng 4, 971–979.
6. Choi, J. H., Lee, S. Y. (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64, 625–635.
7. Baneyx, F., Mujacic, M. (2004) Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 22, 1399–1408.
8. Chan, W., Helms, L. R., Brooks, I., Lee, G., Ngola, S., McNulty, D., Maleeff, B., Hensley, P., Wetzel, R. (1996) Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin VL domain REI. Fold Des 1, 77–89.
9. Knappik, A., Krebber, C., Plückthun, A. (1993) The effect of folding catalysts on the in vivo folding process of different antibody fragments expressed in Escherichia coli. Biotechnology 11, 77–83.
10. Wülfing, C., Plückthun, A. (1994) Protein folding in the periplasm of Escherichia coli. Mol Microbiol 12, 685–692.
11. Bardwell, J. C., McGovern, K., Beckwith, J. (1991) Identification of a protein required for disulfide bond formation in vivo. Cell 67, 581–589.
12. Missiakas, D., Georgopoulos, C., Raina, S. (1994) The Escherichia coli dsbC (xprA) gene encodes a periplasmic protein involved in disulfide bond formation. EMBO J 13, 2013–2020.
13. Shevchik, V. E., Condemine, G., Robert-Baudouy, J. (1994) Characterization of DsbC, a periplasmic protein of Erwinia chrysanthemi and Escherichia coli with disulfide isomerase activity. EMBO J 13, 2007–2012.
14. Fischer, G., Tradler, T., Zarnt, T. (1998) The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding vs. catalysis. FEBS Lett 426, 17–20.
15. Fanghanel, J., Fischer, G. (2004) Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front Biosci 9, 3453–3478.
16. Rouviere, P. E., Gross, C. A. (1996) SurA, a periplasmic protein with peptidyl-prolyl isomerase activity, participates in the assembly of outer membrane porins. Genes Develop 10, 3170–3182.
17. Dartigalongue, C., Raina, S. (1998) A new heat-shock gene, ppiD, encodes a peptidyl-prolyl isomerase required for folding of outer membrane proteins in Escherichia coli. EMBO J 17, 3968–3980.
18. Liu, J., Walsh, C. T. (1990) Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A. Proc Natl Acad Sci USA 87, 4028–4032.
19. Horne, S. M., Young, K. D. (1995) Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. Arch Microbiol 163, 357–365.
20. Lazar, S. W., Kolter, R. (1996) SurA assists the folding of Escherichia coli outer membrane proteins. J Bacteriol 178, 1770–1773.
21. Hennecke, G., Nolte, J., Volkmer-Engert, R., Schneider-Mergener, J., Behrens, S. (2005) The periplasmic chaperone SurA exploits two features characteristic of integral outer membrane proteins for selective substrate recognition. J Biol Chem 280, 23540–23548.
22. Bitto, E., McKay, D. B. (2002) Crystallographic structure of SurA, a molecular chaperone that facilitates folding of outer membrane porins. Structure 10, 1489–1498.
23. Korndörfer, I. P., Dommel, M. K., Skerra, A. (2004) Structure of the periplasmic chaperone Skp suggests functional similarity with cytosolic chaperones despite differing architecture. Nat Struct Mol Biol 11, 1015–1020.
24. Schlapschy, M., Grimm, S., Skerra, A. (2006) A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli. Protein Eng Des Sel 19, 385–390.
25. Selzer, G., Som, T., Itoh, T., Tomizawa, J. (1983) The origin of replication of plasmid p15A and comparative studies on the nucleotide sequences around the origin of related plasmids. Cell 32, 119–129.
26. Alton, N. K., Vapnek, D. (1979) Nucleotide sequence analysis of the chloramphenicol resistance transposon Tn9. Nature 282, 864–869.
27. Skerra, A., Pfitzinger, I., Plückthun, A. (1991) The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. Biotechnology 9, 273–278.
28. Skerra, A. (1994) Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli. Gene 151, 131–135.
29. Sφrensen, H. P., Mortensen, K. K. (2005) Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115, 113–128.
30. Yanisch-Perron, C., Vieira, J., Messing, J. (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33, 103–119.
31. Strauch, K. L., Beckwith, J. (1988) An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. Proc Natl Acad Sci USA 85, 1576–1580.
32. Meerman, H. J., Georgiou, G. (1994) Construction and characterization of a set of E. coli strains deficient in all known loci affecting the proteolytic stability of secreted recombinant proteins. Biotechnology 12, 1107–1110.
33. Schäfer, U., Beck, K., Müller, M. (1999) Skp, a molecular chaperone of Gram-negative bacteria, is required for the formation of soluble periplasmic intermediates of outer membrane proteins. J Biol Chem 274, 24567–24574.
34. Jensen, K. F. (1993) The Escherichia coli K-12 “wild types” W3110 and MG1655 have an rph frameshift mutation that leads to pyrimidine starvation due to low pyrE expression levels. J Bacteriol 175, 3401–3407.
35. Studier, F. W., Moffatt, B. A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189, 113–130.
36. Breustedt, D. A., Schönfeld, D. L., Skerra, A. (2006) Comparative ligand-binding analysis of ten human lipocalins. Biochim Biophys Acta 1764, 161–173.
37. Nasreen, A., Vogt, M., Kim, H. J., Eichinger, A., Skerra, A. (2006) Solubility engineering and crystallization of human apolipoprotein D. Protein Sci 15, 190–199.
38. Schönfeld, D. L., Ravelli, R. B., Mueller, U., Skerra, A. (2008) The 1.8-Å crystal structure of α1-acid glycoprotein (Orosomu-coid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. J Mol Biol 384, 393–405.
39. Chatwell, L., Holla, A., Kaufer, B. B., Skerra, A. (2008) The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site. Mol Immunol 45, 1981–1994.
40. Friedrich, L., Stangl, S., Hahne, H., Küster, B., Köhler, P., Multhoff, G., Skerra, A. (2010) Bacterial production and functional characterization of the Fab fragment of the murine IgG1/λ monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics. Protein Eng Des Sel 23, 161–168.
41. Outchkourov, N. S., Roeffen, W., Kaan, A., Jansen, J., Luty, A., Schuiffel, D., van Gemert, G. J., van de Vegte-Bolmer, M., Sauerwein, R. W., Stunnenberg, H. G. (2008) Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proc Natl Acad Sci USA 105, 4301–4305.
42. Xu, Y., Lewis, D., Chou, C. P. (2008) Effect of folding factors in rescuing unstable heterologous lipase B to enhance its overexpression in the periplasm of Escherichia coli. Appl Microbiol Biotechnol 79, 1035–1044.
43. Xu, Y., Yasin, A., Wucherpfennig, T., Chou, C. P. (2008) Enhancing functional expression of heterologous lipase in the periplasm of Escherichia coli. World J Microbiol Biotechnol 24, 2827–2835.
44. Guo, C., Diao, H., Lian, Y., Yu, H., Gao, H., Zhang, Y., Lin, D. (2009) Recombinant expression and characterization of an epididymis-specific antimicrobial peptide BIN1b/SPAG11E. J Biotechnol 139, 33–37.
45. Skerra, A. (1994) A general vector, pASK84, for cloning, bacterial production, and single-step purification of antibody Fab fragments. Gene 141, 79–84.
46. Sambrook, J., Fritsch, E. F., Maniatis, T. (2001). Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Schiweck, W., Skerra, A. (1995) Fermenter production of an artificial Fab fragment, rationally designed for the antigen cystatin, and its optimized crystallization through constant domain shuffling. Proteins 23, 561–565.
48. Schmidt, T. G., Skerra, A. (2007) The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat Protoc 2, 1528–1535.
49. Bell, G. I., Fong, N. M., Stempien, M. M., Wormsted, M. A., Caput, D., Ku, L. L., Urdea, M. S., Rall, L. B., Sanchez-Pescador, R. (1986) Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 14, 8427–8446.
50. Plückthun, A., Skerra, A. (1989) Expression of functional antibody Fv and Fab fragments in Escherichia coli. Methods Enzymol 178, 497–515.
51. Ewis, H. E., Lu, C. D. (2005) Osmotic shock: a mechanosensitive channel blocker can prevent release of cytoplasmic but not periplasmic proteins. FEMS Microbiol Lett 253, 295–301.